Modern Practices of Vaccination of Children from Perinatal Risk Groups and Necessary Precaution
https://doi.org/10.31631/2073-3046-2020-19-5-98-103
Abstract
Relevance. In perinatal centres problems of timely vaccination of newborns arise more often than in maternity hospitals, as vaccinations against viral hepatitis B and tuberculosis in accordance with the National Calendar are carried out in an early neonatal period and in time coincide with the stage of treatment and rehabilitation of the newborn, which implies medical withdrawal from vaccination. Vaccination of newborns from high perinatal risk groups is one of the problems of modern vaccinology and immunology.
Aims. On the basis of clinical and immunological characteristics of postnatal babies from mothers with gestational diabetes and fetoplacental insufficiency justify the necessity and safety of their vaccination in the maternity hospital of the perinatal center.
Materials & Methods. A cohort retrospective case-control study was conducted, and 135 birth and developmental history and newborn disease were analyzed. Statistical processing was carried out package «Statistica».
Results. The main nosological forms of pathology in maternity mothers and their newborn children, the volume of primary vaccination (against viral hepatitis B, tuberculosis) in maternity hospital in children with perinatal pathology and healthy newborns have been determined, and the reasons for medical contraindications to vaccinations against viral hepatitis B and tuberculosis have been established.
Conclusions. Newborns from high perinatal risk groups can be vaccinated against viral hepatitis B and tuberculosis in the maternity hospital within the time frame specified by the National Calendar of Preventive Vaccinations. In addressing this issue, the fundamental criteria are to assess the clinical condition of newborns from women with gestational diabetes and fetoplacental insufficiency. Changes in immunological values of umbilical cord blood and in children of 1 month of life are not a criterion for medical withdrawal from vaccinations against viral hepatitis B and tuberculosis.
About the Authors
O. A. Kuznetsova
Urals Scientific Research Institute for Maternal and Child Care
Russian Federation
Russian Federation
Olga A. Kuznecova – Cand. Sci. (Med.), epidemiologist
Repina str.1, Yekaterinburg, 1620028
A. A. Golubkova
Central Research Institute of Epidemiology of Rospotrebnadzor
Russian Federation
Russian Federation
Alla A. Golubkova – Professor, leading researcher
Moscow
N. V. Bashmakova
Urals Scientific Research Institute for Maternal and Child Care
Russian Federation
Russian Federation
Nadezhda V. Bashmakova – Professor, Chief Researcher
Repina str.1, Yekaterinburg, 1620028
References
1. Aksenov AN, Bocharov AI, Bashakin NF, et al. Diagnosis of intrauterine infections in newborns in the early neonatal period. Russian medical journal. 2015;(1):36–39 (In Russ.).
2. Kamayeva NG, Chuzhayev YU, Greenberg LM, et al. The role of medical and social factors in the development of bone complications in anti-tuberculosis vaccination. Siberian medical review. 2011;(6):62–64 (In Russ.).
3. Starodubova VI, Mikhail YV, Ivanov AE. Health of the population of Russia in the social context of the 1990s: problems and prospects. M.: Medicine. 2003 (In Russ.).
4. Kulakov VI, Barashnev YI. Newborns of high risk. M.: GEOTAR-media. 2006 (In Russ.).
5. Krasnoproshina LI, Sevastopol TA, Aksenova VA, et al. The role of immunodeficiency in the development of complications in vaccination of children with BCG vaccine. Journal of Microbiology. 2013;(6):50–55 (In Russ.).
6. Levi DT, Pozdniakova AS. Clinical-immunological assessment of children ‘s health during tuberculosis vaccination. Russian Pediatric Journal. 2010;(4):29–31 (In Russ.).
7. Hill H.A., Singleton J.A., Yankey D. et al. Vaccination Coverage by Age 24 Months Among Children Born in 2015 and 2016–National Immunization Survey-Child, United States, 2016-2018. MMWR Morb Mortal Wkly Rep. 2019 Oct 18; 68(41): 913–918.
8. Chistyakov G.N., Remizova I.I., Gazieva I.A., et al. Features of the immune system of children born to women with gestational diabetes. Ross. Journal of Perinatology and Pediatrics. 2015;(2):42–48 (In Russ.).
9. Burumkulova F, Petrukin V. Gestational diabetes mellitus: endocrinological and obstetric aspects. Doctor. 2012;(9):2–5 (In Russ.).
10. Zverev VV, Semenov BF, Haitov RM. Vaccines and vaccination: national leadership. M. GEOTAR-media. 2011 (In Russ.).
11. Logutova LC, Petrukin VA, Bocharov II, et al. Monitoring of newborns born to mothers with gestational diabetes mellitus. Russian Journal of Obstetrician-Gynaecologist. 2013;(2):89–94 (In Russ.).
12. Benjamin MN, Brian A, Bowmaker M, et al. Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response. Vaccine. 2009. September 4: 27(40):5488–5495.
13. Bocquier A, Ward J, Raude J, et al. Socioeconomic differences in childhood vaccination in developed countries: a systematic review of quantitative studies. Expert Rev Vaccines. 2017;16:1107–18.
14. Sanakoyeva LP. Clinical-immunological evaluation of BCG-vaccine process and formation of anti-tuberculosis immunity (clinical-experimental study): Autoref. Dr. Sci. (Med.), Perm 2007:42 (In Russ.).
15. Uchaykin VF, Shamsheva OV. Guide to Clinical Vaccinology. M.: GEOTAR-Media, 2006. (In Russ.).
16. Chereshnev VA, Shmagel KV. Immunology. Moscow: NP «Center for Strategic Partnership,» 2014 (In Russ.).
17. Victoria J. P., Ofer Levy. Developmental biology of the innate immune response: implications for neonatal and infant vaccine development. Pediatr Res. 2009. May;65(5 Pt 2):98R–105R.
Review
For citations:
Kuznetsova O.A., Golubkova A.A., Bashmakova N.V. Modern Practices of Vaccination of Children from Perinatal Risk Groups and Necessary Precaution. Epidemiology and Vaccinal Prevention. 2020;19(5):98-103. (In Russ.) https://doi.org/10.31631/2073-3046-2020-19-5-98-103
Views:
844
Email this article 